-
Court Denies Company’s Bid to Evade Mesothelioma Responsibility
When an individual is diagnosed with malignant mesothelioma, one of the first things they do as part of their quest for justice is to identify the companies responsible for exposing them to asbestos. The list is frequently long, as their work environments typically contained multiple contaminated products. Named defendants often try to evade these claims.
-
UK Mesothelioma Advocates See More White-Collar Workers Being Affected by Asbestos
The United Kingdom has the dubious distinction of having the highest incidence rate of malignant mesothelioma in the world. While the vast majority of those diagnosed with the rare, asbestos-related disease have been those whose professions had them directly handling or working with the carcinogenic material, the last several years have seen a notable shift,
-
Court Denies Colgate Palmolive’s Request to Dismiss Woman’s Mesothelioma Claim
While mesothelioma and ovarian cancer patients who blame talc in Johnson & Johnson’s Baby Powder for their illnesses wait to hear whether they can pursue personal injury claims, victims who have used other products are waging their own legal battles. Colgate-Palmolive has been named in numerous asbestos-contamination suits, and the Supreme Court of New York
-
84-Year-Old Mesothelioma Victim Wins Right to Have Case Heard in NYC
Eighty-four-year-old Gerald Wagner traces his malignant mesothelioma to the years when he served in the U.S. Navy, and on the years following when he worked onboard a freighter. He filed a mesothelioma lawsuit in the New York Asbestos court against U.S. Steel Corporation after tracing his asbestos exposure back to the company. Though U.S. Steel
-
Iowa Supreme Court Reverses Lower Courts in Favor of Mesothelioma Victim’s Family
In a decision that clarifies recently passed state tort laws, the Supreme Court of Iowa reversed the decision of a lower court in favor of a mesothelioma plaintiff, allowing the victim’s family’s case to proceed to a jury trial. At issue was the question of whether a provision in the new laws granted immunity to
-
Following Mesothelioma Claims, Johnson & Johnson to Stop Global Sales of Talc
Facing tens of thousands of mesothelioma and ovarian cancer claims, international consumer giant Johnson & Johnson has announced that it will discontinue global sales of its talc-based baby powder next year. The company had previously halted the sale of the products in the United States and Canada in 2020, replacing the talc in the product
-
Couple Blames His Mesothelioma on Failures of 3M Mask
In 2019, Larry Roemmich was diagnosed with malignant mesothelioma, the rare form of cancer caused by exposure to asbestos. Roeemmich had spent twenty-seven years working at Puget Sound Naval Shipyard (PSNS) as an insulator. Over eight of those years he wore a protective mask manufactured and sold by 3M Company. Roemmich and his wife named
-
Proposed Change in New York Law Would Impact Mesothelioma Victims’ Families
The families of New Yorkers lost to malignant mesothelioma are waiting and watching as New York Governor Kathy Hochul considers a bill that’s been sent to her for signature. The Grieving Families Act (Senate Bill S74A) would be the first change to the state’s wrongful death statute since 1847. It would dramatically expand the damages
-
Study Shows the Right Mesothelioma Surgery is the One the Patient Can Best Tolerate
Not every patient diagnosed with malignant pleural mesothelioma is eligible for surgery, but those who are surgical candidates face a significant dilemma. Should they opt for extrapleural pneumonectomy, an aggressive surgery that removes the pleural membrane, the most affected lung, and all evidence of cancer? Or should they choose the less invasive pleurectomy and decortication
-
New Drug Combination Shows Promise as Second-Line Mesothelioma Treatment
Researchers from The Netherland Cancer Institute in Amsterdam presented the results of a recent mesothelioma study at the recent International Association for the Study of Lung Cancer 2022 World Conference. The PEMMELA study explored whether combining two medications, pembrolizumab (Keytruda) with lenvatinib (Lenvima), would lead to improved median overall survival and progression-free survival in patients
-
Judge Rejects Asbestos Company’s Appeal, Mesothelioma Victim’s Family to Keep Damages Award
It’s been nearly ten years since Stephen Stewart was first diagnosed with malignant mesothelioma, and three years since a South Carolina jury ordered dryer felt company Scapa Waycross, Inc. to pay the man’s family a total of $700,000 — later amended to $1 million — for his economic damages and the pain and suffering that
-
Building Company Must Face Jury in Mesothelioma Case
Malignant mesothelioma lawsuits pit victims of asbestos exposure and their families against the companies that put them at risk. Though individual families may seem disadvantaged when battling billion-dollar companies, the recent case of a worker sickened by asbestos-contaminated joint compound shows that the rules of the justice system level the playing field, giving plaintiffs a fighting
-
Mesothelioma Researchers View NIPEC Treatment with Optimism
Though malignant mesothelioma most frequently develops in the pleural cavity, approximately 15% of victims are diagnosed with peritoneal mesothelioma. The tumors, which appear in the abdominal cavity, are generally treated with a combination of cytoreductive surgery followed by the site being bathed in heated chemotherapy solution. In recent years a new treatment called NIPEC, or
-
Lawsuit Blames Homeowner’s Mesothelioma Death on Product Used in Remodeling Project
Esther D. Mellor died eighteen months after her diagnosis with malignant mesothelioma, but before her death she filed an asbestos lawsuit against Union Carbide Corporation and other defendants. She claimed that she had been exposed to the company’s asbestos in a joint compound used to remodel her home in the 1960s and 1970s. The asbestos
-
J & J Mesothelioma Claims to be Assessed by Famed Mediator
Facing conflicting requests from cancer plaintiffs and Johnson & Johnson’s subsidiary LTL Management, U.S. bankruptcy judge Michael Kaplan has announced that famed mediator Kenneth Feinberg will be providing an independent estimation of the mesothelioma and ovarian cancer claims against the consumer giant.
-
Report Confirms 20-Year Rise in Malignant Mesothelioma Deaths in Women
A study published in the CDC’s Morbidity and Mortality Weekly Report has confirmed what mesothelioma advocates have long suspected: deaths from malignant mesothelioma among women have continued to increase despite the sharp decline in asbestos use.
-
Navy Vet’s Widow Files Mesothelioma Case Against Forklift Companies
Despite objections from two forklift companies, a mesothelioma claim filed by the widow of a Navy veteran will be able to proceed. Patricia Elizabeth Smeal blames asbestos within the forklifts’ brakes for her husband’s death from the rare asbestos-related disease.
-
Court Compels Westinghouse to Provide Evidence in Mesothelioma Case
Malignant mesothelioma lawsuits often feel like David and Goliath battles, pitting everyday citizens against corporate giants. That must certainly be the case for the family of Ann Stadtler, whose quest for justice has them facing off against the Westinghouse company. The family was recently handed a win when the Superior Court of Rhode Island granted
-
Lawsuit Links Dental Products to Man’s Malignant Mesothelioma
Though not exclusively an occupational disease, the rare and deadly form of cancer known as malignant mesothelioma is frequently attributed to workplace exposure to asbestos. While the vast majority of victims come from construction, shipbuilding, and factory environments, others have been exposed simply by working in buildings or with appliances that were fabricated using asbestos
-
Quality of Life Study of Mesothelioma Patients Yields Surprising Results
Patients diagnosed with malignant pleural mesothelioma face a grim prognosis and many tough choices. One of the decisions they have to make regards surgery, and whether to undergo an aggressive procedure called extrapleural pneumonectomy that removes an entire lung plus other affected tissue, or a less aggressive procedure called pleurectomy and decortication, or P/D, which
